Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140M Series B financing round. The round exceeded its original target due to demand from strategically aligned investors including Cambridge Companies SPG, Eni Next (the corporate venture arm of Eni S.p.A), Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners' Blue Ocean Fund, MBX Capital, Oman Investment Authority's IDO Investments, and more.